HCWB
HCWB
NASDAQ · Biotechnology

Hcw Biologics Inc

$0.77
-0.03 (-3.43%)
As of Nov 14, 2:52 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,445.6% upside
Low Target $12.72
Average Target $19.68
High Target $25.92
Current Price $0.77
Current
$0.77
Target
$19.68
$12.72 $19.68 avg $25.92
Scenario Analysis
Bear Case
$12.72
1,545.3%
Low target
Base Case
$19.68
+2,445.6%
Avg target
Bull Case
$25.92
+3,252.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$23.94
-96.8% from high
52-Week Low
$0.76
+1.1% from low
Target vs 52W High
$19.68
-17.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.7%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -92.0%
MRNA
Moderna Inc
Hold 31 32% $149.45 -33.1%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.2%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -33.8%